Since IGF- 1R signaling is crucial for maintaining vascular health, interventions that enhance IGF- 1 bioavailability, improve endothelial function, or promote angiogenesis could help mitigate vascular contributions to sarcopenia
Research indicates roles in reducing acute inflammatory signaling, promoting endothelial and epithelial cell migration, and supporting tissue recovery in skeletal muscle, cardiac, and corneal models
in Regulatory Toxicology and Pharmacology confirmed the favorable safety profile of this compound across multiple evaluated parameters
Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon-like peptide-1 receptor agonist BI 456906
Combined intake reduces fracture risk and muscle weakness